Dr. Laura Murray, a clinical psychologist, is a senior scientist at Johns Hopkins Bloomberg School of Public Health. Murray has extensive expertise in a wide range of evidence-based treatments, including training, implementation, and evaluation. She has conducted evaluations ranging from qualitative understanding of mental/behavioral health, to full randomized trials of treatments all over the world, working with numerous health sectors. She has a passion for innovating new solutions to improve service quality and delivery with a systems approach. Murray publishes extensively in top journals, trains globally, regularly speaks at conferences and organizations, and consults with organizations on skills-training for stress, resilience, and leadership.

Dr. Lucica Ditiu is the executive director of the Stop TB Partnership. She is a Romanian physician, accomplished professional, and leader in the global fight against tuberculosis and other communicable diseases. Ditiu is driven by the firm belief that we should "leave no one behind" and is one of the strongest advocates within the international community in the fight against tuberculosis. A believer in innovation, flexibility, change, breaking the rules and thinking out of the box, Ditiu is dedicated to driving political commitment and engagement to accelerate the efforts to end TB.

Global Health President Dr. Lutz Hegemann is responsible for integrating global health and environmental, social, and governance matters into the core of the Novartis business. This includes our global health programs in communicable and noncommunicable diseases, our business in sub-Saharan Africa as well as the Novartis Foundation. Since joining Novartis in the Consumer Health Division in 2005, Hegemann held roles of increasing responsibility. He began his career as a public health physician and scientist.

Dr. Magda Robalo is the UHC2030 co-chair and interim executive director of Women in Global Health. A visionary leader in global health, she has spearheaded successful initiatives as president and co-founder of the Institute for Global Health and Development, former minister of health of Guinea-Bissau, and senior positions in the World Health Organization Africa region.

Dr. Mamka Anyona is the policy and strategy lead for the U.N. multipartner trust fund for noncommunicable diseases and mental health. She is a global health expert with a decade of experience in the prevention and management of chronic diseases through systems transformation.

Dr. Manica Balasegaram is the executive director of the Global Antibiotic Research and Development Partnership, or GARDP. With over 20 years experience working in global health, Balasegaram is a global health leader and medical professional specializing in infectious diseases and clinical development.

Dr. Marc Sprenger is director of the World Health Organization secretariat for antimicrobial resistance. Marc and this secretariat focus on coordination of an organization-wide approach to antimicrobial resistance, working with WHO programs carrying out technical activities required for the implementation of the global action plan on antimicrobial resistance.

Dr. Mark Hellowell is an associate professor in global health policy at the University of Edinburgh. An internationally renowned expert in health systems, he works with national governments and international organizations, including the World Health Organization, World Bank, and the U.K.’s Foreign, Commonwealth & Development Office.

Dr. Michel Sidibé was appointed as the African Union’s special envoy for the African Medicines Agency in April 2021. Dr. Sidibé has been advocating for a people-centered approach to health and development for over 40 years. Previously, he held several high-level positions, such as the Republic of Mali’s minister of health and social affairs from 2019 to 2020 and executive director at UNAIDS from 2009 to 2019.